The QuickScreen One-Step Rapid Benzodiazepines Test is a rapid, visual, qualitative, competitive binding immunoassay for the detection of Benzodiazepines and Benzodiazepine metabolites in human urine. This assay provides only a preliminary analytical test result. For test situations requiring laboratory confirmation by such methods please refer to the QuickScreen Pro Test Kit . Clinical consideration and professional judgment should be applied to all test results, particularly when preliminary positive results are indicated. They represent a broad class of central nervous system depressants which have anxiolytic, hypnotic, anticonvulsant and muscle relaxant effects.
Chronic abuse can result in addiction and retardive dyskinnesia.
Benzodiazepines are used therapeutically to produce sedation, induce sleep, relieve anxiety and muscle spasms and to prevent seizures. In general, benzodiazepines act as hypnotics in high doses, as anxiolytics in moderate doses and as sedatives in low doses. Like the barbiturates, benzodiazepines differ from one another in how fast they take effect and how long the effects last. Approximately 50 percent of people entering treatment for narcotic or cocaine addiction also report abusing benzodiazepines. The QuickScreen One-Step Rapid Benzodiazepines Test utilizes a unique combination of monoclonal antibodies to selectively identify Benzodiazepines and its major metabolites in urine with a high degree of sensitivity.